Jonathan Sharrett DO

PubMed

• 10 citations
  Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
  Shannon S Wu, Nikhil Joshi, Jonathan Sharrett, Sanjay Rao, Akeesha Shah
  JAMA Otolaryngology-- Head & Neck Surgery. 2023-01-01
• 4 citations
  Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes.
  Siddharth Kunte, Jonathan Sharett, Wei Wei, Christian Nasr, Brandon Prendes
  Anticancer Research. 2022-05-01
• Typically, We Would Observe.
  J.M. Sharrett, John H. Suh
  International Journal of Radiation Oncology, Biology, Physics. 2020-11-01

Abstracts/Posters

• Treatment Outcomes and Patterns of Failure in High Grade Lymphoma of the Thyroid Following Combined Modality Therapy: Single Institution Series
  J.M. Sharrett1, C.S. Shah2, E.S. Murphy2, A.M. Garcia3, D. Jagadeesh3, R. Dean3, B. Hill3, B. Pohlman3, S. Cherian2, ASTRO 2019, Chicago, IL, 9/15/2019
• Factors Associated with Recurrence and Death in Patients with Aggressive Tall Cell Papillary Thyroid Cancer: A Large, Single Institution Series
  J.M. Sharrett1, S. Rao2, H. Li3, A. Shah3, C. Nasr3, J.L. Geiger4, J. Scharpf5, S. Koyfman6, N.P. Joshi6, ASTRO 2019, Chicago, IL, 9/1/2019
• Gender Differences in Clinical Presentation and Treatment Outcomes in Aggressive Tall Cell Papillary Thyroid Carcinoma in A Large, Single Institution Experience
  J.M. Sharrett1, S. Rao2, H. Li3, A. Shah3, C. Nasr3, J.L. Geiger4, J. Scharpf5, S. Koyfman6, N.P. Joshi6, ASTRO 2019, Chicago, IL, 9/1/2019
• Factors associated with recurrence and death in patients with aggressive hobnail morphology papillary thyroid carcinoma.
  Jonathan Matthew Sharrett, Hong Li, Akeesha Shah, Christian Nasr, Joseph Scharpf, Shlomo A. Koyfman, Nikhil Joshi, Jessica Lyn Geiger, ASCO 2019, Chicago, IL, 6/1/2019
• Anatomically Restricted Dose Escalated SBRT to the Pancreas Effects High Local Control and Rapid and Substantial Pain Relief
  J.M. Sharrett, E.I. Sarihan, A. Magnelli, N.M. Woody, K.L. Stephans, M. Abazeed, ASTRO 2018, San Antonio, TX, 11/1/2018
• Tumor Volume Is a Better Predictor of Locoregional Failure Than T and N Staging in Larynx Cancer Patients Treated With Definitive Chemoradiation.
  Sharrett J, Ward MC, Murray E, Belfi C, Xia P, Scharpf J, Lamarre E, Prendes B, Lorenz R, Burkey B, Koyfman S, Woody N, Greskovich JF, Adelstein D, Geiger J, Joshi N, ASTRO 2017; Cleveland Clinic Foundation, San Diego, CA, 9/24/2017
• Multimodality Management of Patients with Esthesioneuroblastoma
  JM Sharrett, W. Jaing, A.S.R Mohamed, M. Horiates, G.B. Gunn, J. Phan, E. Hanna, S.J Frank, M.E. Kupferman, B.M. Beadle, W.O. Arafat, F. De Monte, A.S. Garden, D.I. Ro..., ASTRO 2015 San Antonio, TX, MD Anderson Cancer Center, 10/23/2015
• Join now to see all

Lectures

• Role of Exercise in Mitigating Neurocognitive Decline Following Radiotherapy 
  St. Jude Children's Research Hospital - 8/2019
• Factors associated with recurrence and death in patients with aggressive hobnail morphology papillary thyroid carcinoma. 
  2019 ASCO Annual Meeting - 6/1/2019